News by Tag: Biopharmaceuticals
Biotech Growth to Slow Down in the US
March 18, 2013
Recombinant proteins, which currently account for around 60% of the total US biopharmaceutical sales, are expected to be the worst hit during the forecast period.
March 18, 2013
Recombinant proteins, which currently account for around 60% of the total US biopharmaceutical sales, are expected to be the worst hit during the forecast period.
IMARC Group Releases the Most Comprehensive Report on the Global Biopharmaceutical Market
November 27, 2012
Driven by their target oriented nature that enables them to attack only the diseased cells without affecting the healthy ones, biopharmaceuticals today represent one of the fastest growing segments of the pharmaceutical industry.
November 27, 2012
Driven by their target oriented nature that enables them to attack only the diseased cells without affecting the healthy ones, biopharmaceuticals today represent one of the fastest growing segments of the pharmaceutical industry.
Temperature Sensitive Healthcare Products to Grow Robustly in the Coming Years
November 21, 2012
The share of temperature sensitive healthcare products in the global healthcare market is expected to reach 23% by 2017.
November 21, 2012
The share of temperature sensitive healthcare products in the global healthcare market is expected to reach 23% by 2017.
Biologicals to Drive the Global Cold Chain Logistics Market
November 15, 2012
The strong growth of the global biologicals market is expected to create a huge demand for efficient cold chain logistic services.
November 15, 2012
The strong growth of the global biologicals market is expected to create a huge demand for efficient cold chain logistic services.
Global Healthcare Cold Chain Logistics Market to Reach USD 10.7 Billion by 2017
November 1, 2012
A new report from IMARC Group expects the market for cold chain logistic services to grow at a CAGR of 8% during 2011-2017.
November 1, 2012
A new report from IMARC Group expects the market for cold chain logistic services to grow at a CAGR of 8% during 2011-2017.
High Efficacy & Target Oriented Nature of Biopharmaceuticals Have Increased the Life Expectancies of Patients
October 10, 2011
A new report from IMARC Group finds that one of the biggest advantages of biopharmaceuticals over conventional small molecule drugs is their high efficacy and target oriented nature.
October 10, 2011
A new report from IMARC Group finds that one of the biggest advantages of biopharmaceuticals over conventional small molecule drugs is their high efficacy and target oriented nature.
New Report finds that Cost is Not Always the Most Important Factor in Logistic Decisions
September 22, 2011
Healthcare manufacturers today are becoming more and more receptive to the notion that rather than risking the wastage of such high value products, it is more preferable to pay the extra cash to strengthen their distribution systems.
September 22, 2011
Healthcare manufacturers today are becoming more and more receptive to the notion that rather than risking the wastage of such high value products, it is more preferable to pay the extra cash to strengthen their distribution systems.
The Market for Biosimilars Will be a Marathon and Not a Sprint
July 27, 2011
A new report from IMARC Group expects the US biosimilar market to reach revenues worth US$ 11.4 Billion by 2020. This market, however, unlike small molecule generics, is expected to be a marathon and not a sprint.
July 27, 2011
A new report from IMARC Group expects the US biosimilar market to reach revenues worth US$ 11.4 Billion by 2020. This market, however, unlike small molecule generics, is expected to be a marathon and not a sprint.
Vaccines to Drive the Growth of the Global Healthcare Cold Chain Logistics Market
July 25, 2011
Driven by a strong growth in the sales of vaccines, the demand for efficient cold chain packaging and transportation services is expected to grow robustly in the coming years.
July 25, 2011
Driven by a strong growth in the sales of vaccines, the demand for efficient cold chain packaging and transportation services is expected to grow robustly in the coming years.
Global Healthcare Cold Chain Logistics Market to Reach US$ 9.5 Billion by 2016
July 1, 2011
Driven by a strong growth in the sales of temperature sensitive healthcare products, IMARC Group expects the global healthcare cold chain logistics market to reach values worth US$ 9.5 billion by 2016
July 1, 2011
Driven by a strong growth in the sales of temperature sensitive healthcare products, IMARC Group expects the global healthcare cold chain logistics market to reach values worth US$ 9.5 billion by 2016